HomeCompareWTXR vs JNJ

WTXR vs JNJ: Dividend Comparison 2026

WTXR yields 2222.22% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WTXR wins by $26607504688.23M in total portfolio value
10 years
WTXR
WTXR
● Live price
2222.22%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26607504688.26M
Annual income
$24,443,703,761,807,280.00
Full WTXR calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — WTXR vs JNJ

📍 WTXR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWTXRJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WTXR + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WTXR pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WTXR
Annual income on $10K today (after 15% tax)
$188,888.89/yr
After 10yr DRIP, annual income (after tax)
$20,777,148,197,536,188.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, WTXR beats the other by $20,777,148,197,532,204.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WTXR + JNJ for your $10,000?

WTXR: 50%JNJ: 50%
100% JNJ50/50100% WTXR
Portfolio after 10yr
$13303752344.14M
Annual income
$12,221,851,880,905,984.00/yr
Blended yield
91.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

WTXR
No analyst data
Altman Z
-40.1
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WTXR buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWTXRJNJ
Forward yield2222.22%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$26607504688.26M$30.3K
Annual income after 10y$24,443,703,761,807,280.00$4,689.40
Total dividends collected$26455115546.17M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: WTXR vs JNJ ($10,000, DRIP)

YearWTXR PortfolioWTXR Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$232,922$222,222.22$10,592$272.30+$222.3KWTXR
2$5,086,656$4,837,429.33$11,289$357.73+$5.08MWTXR
3$104,173,443$98,730,720.93$12,123$472.89+$104.16MWTXR
4$2,001,166,924$1,889,701,340.37$13,141$629.86+$2001.15MWTXR
5$36,067,485,611$33,926,237,001.88$14,408$846.81+$36067.47MWTXR
6$610,050,404,477$571,458,194,873.63$16,021$1,151.60+$610050.39MWTXR
7$9,686,139,336,337$9,033,385,403,546.24$18,122$1,588.22+$9686139.32MWTXR
8$144,409,519,569,037$134,045,350,479,156.38$20,930$2,228.20+$144409519.55MWTXR
9$2,022,243,856,495,371$1,867,725,670,556,501.50$24,792$3,191.91+$2022243856.47MWTXR
10$26,607,504,688,257,330$24,443,703,761,807,280.00$30,274$4,689.40+$26607504688.23MWTXR

WTXR vs JNJ: Complete Analysis 2026

WTXRStock

West Texas Resources, Inc. acquires, explores for, and develops oil and gas properties in North America. The company holds a 50% working interest in non-operating leases covering approximately 1,070 gross mineral acre leases in a property located in Hale County, Texas; 1% working interest in an oil prospect located in Floyd County, Texas; 25% working interest in oil and gas properties located in Gregg County, Texas; and 25% working interest in an East Texas oil and gas property. It also holds a 100% interest in Kiowa properties located in North Dakota, Florida, Illinois, and Kentucky. The company was formerly known as Texas Resources Energy, Inc. and changed its name to West Texas Resources, Inc. in June 2011. West Texas Resources, Inc. was founded in 2010 and is headquartered in Frisco, Texas.

Full WTXR Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this WTXR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WTXR vs SCHDWTXR vs JEPIWTXR vs OWTXR vs KOWTXR vs MAINWTXR vs ABBVWTXR vs MRKWTXR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.